SCORTIS LAB PVT LTD
10 TABLETS IN A STRIP
ORAL DIABETIC DRUGS
Primarily Used For: Type II Diabetes mellitus
Alcohol Interaction: Alcohol to be avoided with glimepiride as it increases incidence of hypoglycaemia.
Food Interaction: Should be taken before food
Common Side Effects:
Hypoglycaemia (Low blood sugar level), Nausea, Headache, Dizziness but less with glimepiride compared to other drugs of these group.
.₹ 62.48
40% OFFGlimepiride is used in the treatment of type 2 diabetes mellitus.
Glimetis 2MG Tablet is used in
Glimepiride is used in the treatment of type 2 diabetes mellitus.
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
Hypoglycaemia (Low blood sugar level), Nausea, Headache, Dizziness but less with glimepiride compared to other drugs of these group.
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
LUPIN LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
ARISTO PHARMACEUTICALS PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
GOLD LINE
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
LUPIN LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RONYD HEALTHCARE PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RONYD HEALTHCARE PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RONYD HEALTHCARE PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
GLENMARK PHARMACEUTICALS LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
WOCKHARDT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RONYD HEALTHCARE PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RONYD HEALTHCARE PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
RANBAXY LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
MOREPEN LABORATORIES LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
LUPIN LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
AURZ PHARMACEUTICAL PVT LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
MEDLEY PHARMACEUTICALS
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
MEDLEY PHARMACEUTICALS
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
B A L PHARMA
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
PANACEA BIOTEC LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
PANACEA BIOTEC LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
ABBOTT INDIA LTD
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
MEDLEY PHARMACEUTICALS
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
MEDLEY PHARMACEUTICALS
Glimepiride increases the amount of insulin released by the pancreas, which in turn lowers the blood glucose levels. It also inhibits glucagon release.
B A L PHARMA